Muscle, neoplasm of, malignant (excluding soft tissue sarcoma)—100

Muscle, neoplasm of, malignant (excluding soft tissue sarcoma) 

Malignant neoplasm of muscle refers to the development of cancerous cells within the muscle tissue. This condition excludes soft tissue sarcoma, which is a separate category of malignant tumors originating from various soft tissues. Malignant muscle neoplasms can occur in different muscle groups throughout the body.

Causes and Risk Factors

Malignant neoplasm of muscle might be a result of the following:

  • Genetic mutations or alterations in the DNA of muscle cells.
  • Exposure to certain environmental factors or carcinogens.
  • Family history of certain genetic syndromes associated with muscle cancer, such as Li-Fraumeni syndrome or neurofibromatosis.
  • Previous radiation therapy to the affected area.
  • Weakened immune system, such as in individuals with HIV/AIDS or undergoing immunosuppressive therapy.

Symptoms

Signs and symptoms include:

  • Pain or tenderness in the affected muscle.
  • Swelling or a palpable mass or lump.
  • Muscle weakness or loss of function.
  • Fatigue or unexplained weight loss.
  • Night sweats.
  • Fever or recurrent infections.
  • Changes in the appearance of the overlying skin (e.g., discoloration, ulceration).

Diagnosis

Following tests and exams are performed to establish a definitive diagnosis of a potential malignant neoplasm originating from the muscle.

  • Physical examination to evaluate symptoms and identify any palpable masses.
  • Imaging tests, such as MRI, CT scan, or ultrasound, to visualize the tumor and assess its size, location, and involvement with nearby structures.
  • Biopsy of the tumor for histopathological examination, which helps confirm the presence of cancerous cells and determine the type and grade of the tumor.
  • Blood tests to assess overall health and identify any abnormalities that may be associated with the tumor.

Further diagnostic procedures may be required, such as PET scan or bone scan, to determine the extent of the disease and check for potential metastasis. Staging of the tumor to determine the extent of its spread and guide treatment decisions.

Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of three or more features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with six or more characteristics of disfigurement

80
Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of two features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with four or five characteristics of disfigurement

50
Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of one feature or paired set of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with two or three characteristics of disfigurement

30
Description Percentage

With one characteristic of disfigurement

10

Note (1): The 8 characteristics of disfigurement, for purposes of evaluation under §4.118, are:

Scar 5 or more inches (13 or more cm.) in length. Scar at least one-quarter inch (0.6 cm.) wide at widest part.

Surface contour of scar elevated or depressed on palpation.

Scar adherent to underlying tissue.

Skin hypo-or hyper-pigmented in an area exceeding six square inches (39 sq. cm.).

Skin texture abnormal (irregular, atrophic, shiny, scaly, etc.) in

an area exceeding six square inches (39 sq. cm.).

Underlying soft tissue missing in an area exceeding six square inches (39 sq. cm.).

Skin indurated and inflexible in an area exceeding six square inches (39 sq. cm.).

 

Note (2): Rate tissue loss of the auricle under DC 6207 (loss of auricle) and anatomical loss of the eye under DC 6061 (anatomical loss of both eyes) or DC 6063 (anatomical loss of one eye), as appropriate.

Note (3): Take into consideration unretouched color photographs when evaluating under these criteria.

Note (4): Separately evaluate disabling effects other than disfigurement that are associated with individual scar(s) of the head, face, or neck, such as pain, instability, and residuals of associated muscle or nerve injury, under the appropriate diagnostic code(s) and apply § 4.25 to combine the evaluation(s) with the evaluation assigned under this diagnostic code.

Note (5): The characteristic(s) of disfigurement may be caused by one scar or by multiple scars; the characteristic(s) required to assign a particular evaluation need not be caused by a single scar in order to assign that evaluation.

Description Percentage

With visible or palpable tissue loss and either gross distortion or asymmetry of three or more features or paired sets of features (nose, chin, forehead, eyes (including eyelids), ears (auricles), cheeks, lips), or; with six or more characteristics of disfigurement

80

Need help with Medical Compensation? If your disability claim is not clearly supported by your medical records along with evidence, your claim can be denied. We have helped thousands of Veterans claim the compensation they deserve.

Get More Info